CLASS 4 CAUTION IN USE - Ponstan 250mg Capsules & Ponstan Forte 500mg Tablets

CLASS 4 CAUTION IN USE - Ponstan 250mg Capsules & Ponstan Forte 500mg Tablets

Chemidex pharma ltd has informed the MHRA that the patient information leaflet (PIL) in the cartons for the batches listed in the tables above for Ponstan 250mg capsules and Ponstan Forte 500mg tablets include an out of date PIL, dated March 2020 and January 2021 respectively. The latest PIL, authorised in February 2023 includes updated information related to the use of the product during pregnancy, which is not mentioned in the out of date PILs.” 

MHRA Drug alert date: 27th August 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-chemidex-pharma-ltd-ponstan-250mg-capsules-and-500mg-tablets-mefenamic-acid-el-24-a-slash-40?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=971b62a0-6294-430f-8887-9e276c779eb6&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please email essentialpharmaUK@EU.ProPharmaGroup.com , or telephone +44 (0)1423 850700.

For stock control enquiries please email commercial@essentialpharmagroup.com.